Related Experiment Video
Updated: Apr 3, 2026
09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
3.6K
Next generation sequencing for newborn screening: are we there yet?
1Director,Oncogenetics Unit,Institute of Human Genetics, Chaim Sheba Medical Center,Tel-Hashomer,Israel.
Genetics Research
|September 23, 2015
Summary
Newborn screening programs identify severe, rare conditions in infants early. This public health initiative improves infant health outcomes and quality of life through timely diagnosis and treatment.
Area of Science:
- Public Health
- Neonatal Medicine
- Biochemistry
Background:
- Newborn screening (NBS) programs are widely adopted in Western countries.
- The primary objective is the early detection of severe, rare, and treatable infant conditions.
- These programs are recognized as significant public health achievements.
Purpose of the Study:
- To highlight the importance and implementation of newborn screening.
- To emphasize the benefits of early detection and treatment for infant health.
- To describe the technical aspects of current newborn screening processes.
Main Methods:
- Screening is conducted on asymptomatic newborns approximately 48 hours after birth.
- A small blood sample is collected on a dried blood spot card.
- Biochemical analysis, primarily using mass spectrometry, is performed on the samples.
Main Results:
- NBS programs have led to saving lives and enhancing infant quality of life.
- Early diagnosis and treatment ensure better short-term and long-term health outcomes.
- These programs reduce the overall financial burden on healthcare systems.
Conclusions:
- Newborn screening is a crucial public health strategy for managing infant health.
- Timely intervention based on NBS results significantly improves infant health trajectories.
- The current NBS methodology, utilizing dried blood spots and mass spectrometry, is effective.
Related Concept Videos
03:00Next-generation Sequencing
101.5K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
101.5K
01:57Sanger Sequencing
778.8K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
778.8K
03:21RNA-seq
12.6K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.6K